| Financial Year |
March 31 2023 |
| Monetary Funds |
2,324,784,528.31 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,074,564,575.87 |
| Advances to Suppliers |
888,967.27 |
| Other Receivables |
13,239,397.12 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
5,920,000.00 |
| Dividend Receivable |
-- |
| Inventories |
2,222,906.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
112,548.44 |
| Total Current Assets |
3,439,281,473.65 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
120,774,425.88 |
| Investment Properties |
-- |
| Fixed Assetes |
3,171,029,770.84 |
| Under-construction Projects |
256,123,923.94 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
43,541,222.68 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
218,627.44 |
| Deferred Income Tax Assets |
37,792,342.86 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
3,652,021,752.02 |
| Total Assets |
7,091,303,225.67 |
| Short-Term Loans |
280,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
190,000,000.00 |
| Accounts Payable |
1,595,152,869.78 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
21,278,348.68 |
| Taxes Payable |
35,134,515.99 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
149,021,402.10 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
12,488,381.65 |
| Other Current Liabilities |
6,509,502.97 |
| Sub-Total of Current Liabilities |
2,343,351,674.69 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
19,349.40 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
18,117,226.77 |
| Total Liabilities |
2,361,468,901.46 |
| Paid-In Capital(Or Share Stock) |
914,608,128.00 |
| Capital Surplus |
1,968,130,998.25 |
| Surplus Reserve |
182,292,311.29 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,664,802,886.67 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,729,834,324.21 |
| Owner's Equity（Stockholder's Equity） |
4,729,834,324.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,091,303,225.67 |
